https://www.cambridgebiocapital.com/search https://www.cambridgebiocapital.com https://www.cambridgebiocapital.com/issue/akamis-bio-has-raised-30-million-funding https://www.cambridgebiocapital.com/issue/albumedix-is-acquired-for-415-million https://www.cambridgebiocapital.com/issue/aldena-therapeutics-raises-30-million-investment https://www.cambridgebiocapital.com/issue/amphista-therapeutics-partners-with-bms-merck https://www.cambridgebiocapital.com/issue/antiverse-has-raised-3-million-funding https://www.cambridgebiocapital.com/issue/astronautx-raises-61-million-series-a-dupree-lab-awarded-1-million-grant-cambridge-launches-founders-led-by-gerard-grech https://www.cambridgebiocapital.com/issue/bloomsbury-genetic-therapies-emerges-from-stealth https://www.cambridgebiocapital.com/issue/booby-biome-raises-1-3-million-pre-seed-funding https://www.cambridgebiocapital.com/issue/british-destiny-pharma-enters-472-million-collaboration-with-us-sebela-pharmaceuticals https://www.cambridgebiocapital.com/issue/cambridge-biocapital-001-moderna-to-open-mrna-r-d-facility-in-the-uk https://www.cambridgebiocapital.com/issue/carlyle-to-acquire-abingworth https://www.cambridgebiocapital.com/issue/constructive-bio-has-emerged-from-stealth-raising-15-million https://www.cambridgebiocapital.com/issue/convatec-acquires-30technologys-antimicrobial-platform-for-45-million https://www.cambridgebiocapital.com/issue/ducentis-biotherapeutics-has-been-acquired-for-400-million https://www.cambridgebiocapital.com/issue/eagle-genomics-raises-20-million https://www.cambridgebiocapital.com/issue/elasmogen-has-raised-8-million-round https://www.cambridgebiocapital.com/issue/empyrean-neurosciences-launches-with-22-million-series-a https://www.cambridgebiocapital.com/issue/epsilogen-raised-42m-series-b-microbiotica-raised-67m-series-b https://www.cambridgebiocapital.com/issue/evonetix-has-raised-24-million-investment https://www.cambridgebiocapital.com/issue/gilead-has-acquired-mirobio-for-405-million https://www.cambridgebiocapital.com/issue/grey-wolf-therapeutics-has-raised-49-million-series-b https://www.cambridgebiocapital.com/issue/innovate-uk-budget-boosted-to-1-billion https://www.cambridgebiocapital.com/issue/iq-capital-backs-boltzbits-generative-ai https://www.cambridgebiocapital.com/issue/janssen-legend-biotech-bcma-car-t-therapy-gets-fda-clearance https://www.cambridgebiocapital.com/issue/laverock-therapeutics-has-emerged-from-stealth https://www.cambridgebiocapital.com/issue/m-m-bio-backed-thirtyfivebio-emerges-raising-20-million-seed-funding https://www.cambridgebiocapital.com/issue/maxion-therapeutics-has-raised-16-million-series-a https://www.cambridgebiocapital.com/issue/mirobio-raises-97m-series-b https://www.cambridgebiocapital.com/issue/moa-technology-raises-35-million-series-b https://www.cambridgebiocapital.com/issue/olster-diagnostics-is-seeking-to-raise-100-million-series-c https://www.cambridgebiocapital.com/issue/omass-therapeutics-raises-100-million-series-b https://www.cambridgebiocapital.com/issue/opto-biosystems-launches-with-1-85-million-pre-seed-funding https://www.cambridgebiocapital.com/issue/osler-diagnostics-has-raised-85-million-series-c https://www.cambridgebiocapital.com/issue/oxford-cancer-analytics-has-raised-3-7-million-follow-on-funding https://www.cambridgebiocapital.com/issue/oxford-science-enterprise-raises-250-million-fund https://www.cambridgebiocapital.com/issue/pheon-therapeutics-emerges-from-stealth-raising-68m-series-a https://www.cambridgebiocapital.com/issue/pulmocide-has-raised-52-million-extended-series-c https://www.cambridgebiocapital.com/issue/qkine-has-raised-4-3-million-funding https://www.cambridgebiocapital.com/issue/record-funding-for-uk-university-spin-outs-in-2021 https://www.cambridgebiocapital.com/issue/record-vc-investment-for-british-biotechs https://www.cambridgebiocapital.com/issue/relation-therapeutics-raises-25-million-seed-funding https://www.cambridgebiocapital.com/issue/rq-biotechnology-has-entered-clinical-trials https://www.cambridgebiocapital.com/issue/synaptixbio-secures-13-2-million-seed-round https://www.cambridgebiocapital.com/issue/syncona-backed-mosaic-therapeutics-raises-22-5-million-series-a https://www.cambridgebiocapital.com/issue/synthesis-capital-has-raised-238-million-foodtech-fund https://www.cambridgebiocapital.com/issue/the-crick-secures-1-billion-funding https://www.cambridgebiocapital.com/issue/transition-bio-has-raised-50-million-series-a https://www.cambridgebiocapital.com/issue/tropic-biosciences-raises-35-million https://www.cambridgebiocapital.com/issue/v7-labs-raises-33-million-series-a